New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

Africa’s pharmaceutical future is at a critical juncture with developments shedding light on the continent’s reliance on external aid for vaccine access. The Trump administration’s initial freeze on ...

The company – led by Mark McKenna ... It was led by venture capital firm ARCH Venture Partners, with other prominent biotech investors participating, including OrbiMed, Fairmount, Fidelity ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

Silexion Therapeutics is a clinical-stage, oncology-focused biotechnology company developing RNA interference therapies to treat solid tumors driven by KRAS mutations, the most common oncogenic ...

The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

Pacific Biosciences has moved into its new headquarters at 1305 O'Brien Drive in the Menlo Park Labs office complex in Menlo ...

The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...